Literature DB >> 16551333

Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C?

Annarosa Floreani, Eliseo Minola, Isabella Carderi, Francesco Ferrara, Erik Rosa Rizzotto, Vincenzo Baldo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16551333     DOI： 10.1111/j.1532-5415.2006.00643_4.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  12 in total

1.  Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection.

Authors:  Claudia Roeder; Sabine Jordan; Julian Schulze Zur Wiesch; Heike Pfeiffer-Vornkahl; Dietrich Hueppe; Stefan Mauss; Elmar Zehnter; Sabine Stoll; Ulrich Alshuth; Ansgar W Lohse; Stefan Lueth
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

Review 2.  Viral hepatitis in elderly haemodialysis patients: current prevention and management strategies.

Authors:  Matthias Girndt
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Antiviral Therapy in Elderly Patients With Hepatitis C Virus Infection.

Authors:  Justin Rheem; Vinay Sundaram; Sammy Saab
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-05

Review 4.  Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens.

Authors:  Umberto Vespasiani-Gentilucci; Giovanni Galati; Paolo Gallo; Antonio De Vincentis; Elisabetta Riva; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

5.  Predictive factors for response to peginterferon-alpha and ribavirin treatment of chronic HCV infection in patients aged 65 years and more.

Authors:  Edoardo G Giannini; Monica Basso; Vincenzo Savarino; Antonino Picciotto
Journal:  Dig Dis Sci       Date:  2010-09-18       Impact factor: 3.199

6.  Hepatitis C: Should antiviral therapy be offered to elderly patients?

Authors:  Annarosa Floreani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09       Impact factor: 46.802

Review 7.  Hepatitis C in the elderly: epidemiology, natural history, and treatment.

Authors:  Ayse L Mindikoglu; Ram R Miller
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-12       Impact factor: 11.382

Review 8.  Hepatitis C virus infection in the elderly: epidemiology, natural history and management.

Authors:  Francesca Cainelli
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 9.  Chronic hepatitis C in the aged: much ado about nothing or nothing to do?

Authors:  Stephen Malnick; Yaakov Maor; Ehud Melzer; Sari Tal
Journal:  Drugs Aging       Date:  2014-05       Impact factor: 3.923

Review 10.  Liver physiology and liver diseases in the elderly.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.